BCPC moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 59%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on BCPC as a result. In 47 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The 10-day moving average for BCPC crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 35%.
Following a +4.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCPC advanced for three days, in 165 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 100 of 249 cases where BCPC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 40%.
The 10-day RSI Indicator for BCPC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 21 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Moving Average Convergence Divergence Histogram (MACD) for BCPC turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 25 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCPC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
BCPC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. BCPC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.269) is normal, around the industry mean (2.284). P/E Ratio (34.002) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (3.265) is also within normal values, averaging (1.548). Dividend Yield (0.022) settles around the average of (0.039) among similar stocks. P/S Ratio (4.998) is also within normal values, averaging (48.960).
The 10-day moving average for GEVO crossed bullishly above the 50-day moving average on November 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 73 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +33.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 187 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
GEVO broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GEVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. GEVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
BCPC | GEVO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 47 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 69 | 100 | |
SMR RATING 1..100 | 62 | 98 | |
PRICE GROWTH RATING 1..100 | 49 | 38 | |
P/E GROWTH RATING 1..100 | 45 | 22 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEVO's Valuation (38) in the Chemicals Specialty industry is somewhat better than the same rating for BCPC (83). This means that GEVO’s stock grew somewhat faster than BCPC’s over the last 12 months.
BCPC's Profit vs Risk Rating (69) in the Chemicals Specialty industry is in the same range as GEVO (100). This means that BCPC’s stock grew similarly to GEVO’s over the last 12 months.
BCPC's SMR Rating (62) in the Chemicals Specialty industry is somewhat better than the same rating for GEVO (98). This means that BCPC’s stock grew somewhat faster than GEVO’s over the last 12 months.
GEVO's Price Growth Rating (38) in the Chemicals Specialty industry is in the same range as BCPC (49). This means that GEVO’s stock grew similarly to BCPC’s over the last 12 months.
GEVO's P/E Growth Rating (22) in the Chemicals Specialty industry is in the same range as BCPC (45). This means that GEVO’s stock grew similarly to BCPC’s over the last 12 months.
| BCPC | GEVO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 58% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 57% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 57% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 46% | 1 day ago 79% |
| Advances ODDS (%) | 10 days ago 56% | 1 day ago 84% |
| Declines ODDS (%) | 1 day ago 60% | N/A |
| BollingerBands ODDS (%) | 1 day ago 54% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 40% | 1 day ago 88% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BCPC’s FA Score shows that 0 FA rating(s) are green while GEVO’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BCPC’s TA Score shows that 6 TA indicator(s) are bullish while GEVO’s TA Score has 5 bullish TA indicator(s).
BCPC (@Chemicals: Specialty) experienced а -4.10% price change this week, while GEVO (@Chemicals: Specialty) price change was +52.46% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.17%. For the same industry, the average monthly price growth was -4.83%, and the average quarterly price growth was -10.65%.
BCPC is expected to report earnings on Feb 19, 2027.
GEVO is expected to report earnings on Mar 11, 2027.
The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
A.I.dvisor indicates that over the last year, BCPC has been loosely correlated with ASIX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BCPC jumps, then ASIX could also see price increases.
| Ticker / NAME | Correlation To BCPC | 1D Price Change % | ||
|---|---|---|---|---|
| BCPC | 100% | -0.55% | ||
| ASIX - BCPC | 54% Loosely correlated | +2.01% | ||
| REX - BCPC | 43% Loosely correlated | +0.75% | ||
| RPM - BCPC | 43% Loosely correlated | -2.51% | ||
| OLN - BCPC | 42% Loosely correlated | -1.29% | ||
| HUN - BCPC | 41% Loosely correlated | -1.23% | ||
More | ||||
A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with RPC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then RPC could also see price increases.
| Ticker / NAME | Correlation To GEVO | 1D Price Change % | ||
|---|---|---|---|---|
| GEVO | 100% | +2.20% | ||
| RPC - GEVO | 38% Loosely correlated | -3.05% | ||
| ASPI - GEVO | 36% Loosely correlated | -4.59% | ||
| SSL - GEVO | 28% Poorly correlated | +1.78% | ||
| GPRE - GEVO | 28% Poorly correlated | +0.15% | ||
| BCPC - GEVO | 28% Poorly correlated | -0.55% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ZJUN | 27.74 | -0.02 | -0.06% |
| Innovator Equity Defined Protection ETF - 1 Yr June (ZJUN) | |||
| JULP | 33.22 | -0.08 | -0.25% |
| PGIM S&P 500 Buffer 12 ETF - July (JULP) | |||
| NBOS | 28.22 | -0.10 | -0.35% |
| Neuberger Option Strategy ETF (NBOS) | |||
| SMMD | 86.85 | -1.16 | -1.32% |
| iShares Russell 2500 ETF (SMMD) | |||
| FIGG | 11.19 | -0.17 | -1.48% |
| Leverage Shares 2x Long FIG Daily ETF (FIGG) | |||